{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:06:38Z","timestamp":1777475198735,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["MND-MAB-D-112-111"],"award-info":[{"award-number":["MND-MAB-D-112-111"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"Taiwan Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["111-2320-B-016-004"],"award-info":[{"award-number":["111-2320-B-016-004"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 109-2320-B-016-003 -MY2"],"award-info":[{"award-number":["MOST 109-2320-B-016-003 -MY2"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["109-2320-B-016 -003 -MY2"],"award-info":[{"award-number":["109-2320-B-016 -003 -MY2"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005866","name":"Far Eastern Memorial Hospital","doi-asserted-by":"publisher","award":["FEMH-2019-C-027"],"award-info":[{"award-number":["FEMH-2019-C-027"]}],"id":[{"id":"10.13039\/501100005866","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.bcp.2024.116096","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T11:12:20Z","timestamp":1709032340000},"page":"116096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Cav3.1 T-type calcium channel blocker NNC 55-0396 reduces atherosclerosis by increasing cholesterol efflux"],"prefix":"10.1016","volume":"222","author":[{"given":"Min-Chien","family":"Tsai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rou-Ling","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin-Sheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Sin","family":"Jheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Feng","family":"Lien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Chang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4767-9570","authenticated-orcid":false,"given":"Bing-Hsiean","family":"Tzeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bcp.2024.116096_b0005","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2024.116096_b0010","first-page":"666","article-title":"Monocytes","volume":"10","author":"Flynn","year":"2019","journal-title":"Macrophages, and Metabolic Disease in Atherosclerosis, Front Pharmacol"},{"issue":"10","key":"10.1016\/j.bcp.2024.116096_b0015","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/CIRCRESAHA.119.312617","article-title":"HDL and reverse cholesterol transport","volume":"124","author":"Ouimet","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2024.116096_b0020","article-title":"Liver X receptors: regulators of cholesterol metabolism","volume":"11","author":"Bilotta","year":"2020","journal-title":"Inflammation, Autoimmunity, and Cancer, Front Immunol"},{"issue":"11","key":"10.1016\/j.bcp.2024.116096_b0025","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/pro.3496","article-title":"The nuclear receptor superfamily: a structural perspective","volume":"27","author":"Weikum","year":"2018","journal-title":"Protein Sci."},{"issue":"8","key":"10.1016\/j.bcp.2024.116096_b0030","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41574-018-0037-x","article-title":"Liver X receptors in lipid signalling and membrane homeostasis","volume":"14","author":"Wang","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"10.1016\/j.bcp.2024.116096_b0035","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/cvr\/cvy023","article-title":"Vascular smooth muscle contraction in hypertension","volume":"114","author":"Touyz","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"21","key":"10.1016\/j.bcp.2024.116096_b0040","doi-asserted-by":"crossref","first-page":"3I","DOI":"10.1016\/0002-9149(90)91256-6","article-title":"Atherogenesis, calcium and calcium antagonists","volume":"66","author":"Henry","year":"1990","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116096_b0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1152\/physrev.00018.2002","article-title":"Molecular physiology of low-voltage-activated t-type calcium channels","volume":"83","author":"Perez-Reyes","year":"2003","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.bcp.2024.116096_b0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF03020488","article-title":"Calcium channels\u2013basic aspects of their structure, function and gene encoding; anesthetic action on the channels\u2013a review","volume":"49","author":"Yamakage","year":"2002","journal-title":"Can. J. Anaesth."},{"issue":"1","key":"10.1016\/j.bcp.2024.116096_b0055","first-page":"Cd003654","article-title":"Calcium channel blockers versus other classes of drugs for hypertension","volume":"1","author":"Zhu","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"issue":"13","key":"10.1016\/j.bcp.2024.116096_b0060","first-page":"1503","article-title":"Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events","volume":"102","author":"Pitt","year":"2000","journal-title":"PREVENT Investigators, Circulation"},{"issue":"12","key":"10.1016\/j.bcp.2024.116096_b0065","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.jacc.2004.02.047","volume":"43","author":"Bestehorn","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.bcp.2024.116096_b0070","first-page":"1689","article-title":"Antiatherosclerotic hopes of calcium channel blockers","volume":"15","author":"Uetake","year":"2005","journal-title":"Clin. Calcium"},{"issue":"6","key":"10.1016\/j.bcp.2024.116096_b0075","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/01.fjc.0000187976.60262.bf","article-title":"Divergent action of calcium channel blockers on ATP-binding cassette protein expression","volume":"46","author":"Hasegawa","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2024.116096_b0080","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/1074248414530508","article-title":"Calcium channel blockers in cardiovascular pharmacotherapy","volume":"19","author":"Godfraind","year":"2014","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.bcp.2024.116096_b0085","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4161\/chan.5.6.17996","article-title":"Multi-tasking at the protein level: L-type calcium channels function as ionotropic and metabotropic activators of smooth muscle contraction","volume":"5","author":"Braun","year":"2011","journal-title":"Channels (Austin)"},{"issue":"2","key":"10.1016\/j.bcp.2024.116096_b0090","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00424-017-2068-x","article-title":"Deletion of T-type calcium channels Ca(v)3.1 or Ca(v)3.2 attenuates endothelial dysfunction in aging mice","volume":"470","author":"Thuesen","year":"2018","journal-title":"Pflugers Arch."},{"issue":"3","key":"10.1016\/j.bcp.2024.116096_b0095","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/cvr\/cvs257","article-title":"The Ca(v)3.1 T-type calcium channel is required for neointimal formation in response to vascular injury in mice","volume":"96","author":"Tzeng","year":"2012","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.bcp.2024.116096_b0100","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/cvr\/cvu166","article-title":"T-type calcium channels are involved in hypoxic pulmonary hypertension","volume":"103","author":"Chevalier","year":"2014","journal-title":"Cardiovasc. Res."},{"issue":"3\u20134","key":"10.1016\/j.bcp.2024.116096_b0105","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.vph.2010.06.002","article-title":"Evidence both L-type and non-L-type voltage-dependent calcium channels contribute to cerebral artery vasospasm following loss of NO in the rat","volume":"53","author":"McNeish","year":"2010","journal-title":"Vasc.Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2024.116096_b0110","doi-asserted-by":"crossref","first-page":"C1414","DOI":"10.1152\/ajpcell.00488.2009","article-title":"Involvement of CaV3.1 T-type calcium channels in cell proliferation in mouse preadipocytes","volume":"298","author":"Oguri","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116096_b0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1124\/jpet.103.060814","article-title":"NNC 55\u20130396 [(1S,2S)-2-(2-(N-[(3-benzimidazol-2-yl)propyl]-N-methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride]: a new selective inhibitor of T-type calcium channels","volume":"309","author":"Huang","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2024.116096_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114581","article-title":"An octimibate derivative, Oxa17, enhances cholesterol efflux and exerts anti-inflammatory and atheroprotective effects in experimental atherosclerosis","volume":"188","author":"Tsui","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116096_b0125","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1124\/pr.119.017897","article-title":"Brothers in arms: ABCA1- and ABCG1-mediated cholesterol efflux as promising targets in cardiovascular disease treatment","volume":"72","author":"Frambach","year":"2020","journal-title":"Pharmacol. Rev."},{"issue":"5","key":"10.1016\/j.bcp.2024.116096_b0130","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1172\/JCI59817","article-title":"Liver LXR\u03b1 expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice","volume":"122","author":"Zhang","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"3\u20134","key":"10.1016\/j.bcp.2024.116096_b0135","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1089\/hum.2019.245","article-title":"Exosome-mediated transfer of anti-miR-33a-5p from transduced endothelial cells enhances macrophage and vascular smooth muscle cell cholesterol efflux","volume":"31","author":"Stamatikos","year":"2020","journal-title":"Hum. Gene Ther."},{"issue":"9","key":"10.1016\/j.bcp.2024.116096_b0140","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1194\/jlr.M024471","article-title":"Quercetin enhances ABCA1 expression and cholesterol efflux through a p38-dependent pathway in macrophages","volume":"53","author":"Chang","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bcp.2024.116096_b0145","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fcvm.2018.00151","article-title":"Endothelial-vascular smooth muscle cells interactions in atherosclerosis","volume":"5","author":"Li","year":"2018","journal-title":"Front Cardiovasc Med"},{"issue":"8","key":"10.1016\/j.bcp.2024.116096_b0150","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1172\/JCI32057","article-title":"Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo","volume":"117","author":"Wang","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bcp.2024.116096_b0155","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s12967-022-03542-0","article-title":"Asprosin inhibits macrophage lipid accumulation and reduces atherosclerotic burden by up-regulating ABCA1 and ABCG1 expression via the p38\/Elk-1 pathway","volume":"20","author":"Zou","year":"2022","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.bcp.2024.116096_b0160","first-page":"7","article-title":"Effect of amlodipine, cilnidipine and diltiazem on lipid profiles of hypertensive rats fed with high fat diet: a comparative study","volume":"54","author":"Nim Bahadu rDangi","year":"2016","journal-title":"Bulletin of Faculty of Pharmacy, Cairo University"},{"issue":"9","key":"10.1016\/j.bcp.2024.116096_b0165","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00392-017-1106-1","article-title":"HDL cholesterol: reappraisal of its clinical relevance","volume":"106","author":"M\u00e4rz","year":"2017","journal-title":"Clin. Res. Cardiol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116096_b0170","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1194\/jlr.M003145","article-title":"Cholesterol efflux to apoA-I in ABCA1-expressing cells is regulated by Ca2+-dependent calcineurin signaling","volume":"51","author":"Karwatsky","year":"2010","journal-title":"J. Lipid Res."},{"issue":"7","key":"10.1016\/j.bcp.2024.116096_b0175","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/ATVBAHA.110.203927","article-title":"Calmodulin interacts with ATP binding cassette transporter A1 to protect from calpain-mediated degradation and upregulates high-density lipoprotein generation","volume":"30","author":"Iwamoto","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116096_b0180","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0022-3565(24)35373-X","article-title":"A mibefradil metabolite is a potent intracellular blocker of L-type Ca(2+) currents in pancreatic beta-cells","volume":"292","author":"Wu","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"7","key":"10.1016\/j.bcp.2024.116096_b0185","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1124\/dmd.107.020115","article-title":"The mibefradil derivative NNC55-0396, a specific T-type calcium channel antagonist, exhibits less CYP3A4 inhibition than mibefradil","volume":"36","author":"Bui","year":"2008","journal-title":"Drug Metab. Dispos."},{"issue":"5","key":"10.1016\/j.bcp.2024.116096_b0190","doi-asserted-by":"crossref","first-page":"173","DOI":"10.14740\/cr497w","article-title":"Serum triglyceride lowering effect of cilnidipine in patients with essential hypertension","volume":"7","author":"Kumar","year":"2016","journal-title":"Cardiol Res"},{"issue":"4","key":"10.1016\/j.bcp.2024.116096_b0195","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/ATVBAHA.116.307344","article-title":"Inhibition of Orai1 store-operated Calcium Channel prevents foam cell formation and atherosclerosis","volume":"36","author":"Liang","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224000790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224000790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:51:55Z","timestamp":1777384315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224000790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":39,"alternative-id":["S0006295224000790"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116096","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cav3.1 T-type calcium channel blocker NNC 55-0396 reduces atherosclerosis by increasing cholesterol efflux","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116096"}}